Carlsbad, California (April 11, 2023) - RCE Technologies, Inc.
Heart disease is a leading cause of death worldwide, and heart attacks are a particularly dangerous form of heart disease. When someone experiences a heart attack, it's crucial to identify and treat it quickly to prevent further damage to the heart and increase the chances of survival. That's why researchers at the University of Washington are working on a new study aimed at improving heart attack identification.
Led by Dr. Geoffrey Nichol, the study will focus on using advanced technology to identify heart attacks in out of hospital cardiac arrest (OHCA) patients. Specifically, the researchers will be using RCE's transdermal biomarker sensor wearable, Tropsensor, to get an early assessment of the patient's Troponin levels, a key biomarker used by clinicians in diagnosing a heart attack.
Overall, this study has the potential to significantly improve the way we identify and treat heart attacks in OHCA patients. If successful, this study could pave the way for more advanced and effective integration of the wearable with emergency medical services (EMS) in the future.
RCE.ai, an AI based med tech company works towards the early detection of heart attacks. We have re-imagined the way cardiac proteins are monitored in the blood using a non-invasive transdermal technique. The point of care trending of the composite of acute cardiac injury biomarkers can empower emergency medicine physicians and cardiologists in the early assessment and appropriate risk stratification of patients presenting with chest pain. The company is actively conducting clinical validation trials and undertaking premarket efforts.